These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 11390655)

  • 41. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes.
    Pagano E; Calvo JC
    J Cell Biochem; 2003 Oct; 90(3):561-72. PubMed ID: 14523990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells.
    Mincione G; Piccirelli A; Lazzereschi D; Salomon DS; Colletta G
    J Cell Physiol; 1998 Aug; 176(2):383-91. PubMed ID: 9648926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
    Ram TG; Schelling ME; Hosick HL
    Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis.
    Zeng F; Zhang MZ; Singh AB; Zent R; Harris RC
    Mol Biol Cell; 2007 Nov; 18(11):4446-56. PubMed ID: 17761534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. β-Heregulin impairs EGF induced PLC-γ1 signalling in human breast cancer cells.
    Rommerswinkel N; Keil S; Adawy A; Hengstler JG; Niggemann B; Zänker KS; Dittmar T
    Cell Signal; 2018 Dec; 52():23-34. PubMed ID: 30165102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y; Li X; Jiang J; Frank SJ
    Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential signaling by an anti-p185(HER2) antibody and heregulin.
    Le XF; Vadlamudi R; McWatters A; Bae DS; Mills GB; Kumar R; Bast RC
    Cancer Res; 2000 Jul; 60(13):3522-31. PubMed ID: 10910064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells.
    Bowers G; Reardon D; Hewitt T; Dent P; Mikkelsen RB; Valerie K; Lammering G; Amir C; Schmidt-Ullrich RK
    Oncogene; 2001 Mar; 20(11):1388-97. PubMed ID: 11313882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HER2 oncogenic function escapes EGFR tyrosine kinase inhibitors via activation of alternative HER receptors in breast cancer cells.
    Kong A; Calleja V; Leboucher P; Harris A; Parker PJ; Larijani B
    PLoS One; 2008 Aug; 3(8):e2881. PubMed ID: 18682844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2.
    Harris LN; Yang L; Tang C; Yang D; Lupu R
    Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis.
    Yen L; You XL; Al Moustafa AE; Batist G; Hynes NE; Mader S; Meloche S; Alaoui-Jamali MA
    Oncogene; 2000 Jul; 19(31):3460-9. PubMed ID: 10918604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heregulin enhances regenerative proliferation in postnatal rat utricular sensory epithelium after ototoxic damage.
    Zheng JL; Frantz G; Lewis AK; Sliwkowski M; Gao WQ
    J Neurocytol; 1999; 28(10-11):901-12. PubMed ID: 10900093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop.
    Selitrennik M; Lev S
    Oncotarget; 2015 Sep; 6(26):22214-26. PubMed ID: 26084289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased concentrations of growth factors and activation of the EGFR system in breast cancer.
    Olsen DA; Bechmann T; Østergaard B; Wamberg PA; Jakobsen EH; Brandslund I
    Clin Chem Lab Med; 2012 Oct; 50(10):1809-18. PubMed ID: 23089711
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells.
    Cohen BD; Kiener PA; Green JM; Foy L; Fell HP; Zhang K
    J Biol Chem; 1996 Nov; 271(48):30897-903. PubMed ID: 8940074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines.
    deFazio A; Chiew YE; Sini RL; Janes PW; Sutherland RL
    Int J Cancer; 2000 Aug; 87(4):487-98. PubMed ID: 10918187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC-γ1 signalling in breast cancer cell migration and dissemination.
    Balz LM; Bartkowiak K; Andreas A; Pantel K; Niggemann B; Zänker KS; Brandt BH; Dittmar T
    J Pathol; 2012 Jun; 227(2):234-44. PubMed ID: 22262199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of HER/erbB family of receptor tyrosine kinases and induction of differentiation by glial growth factor 2 in human rhabdomyosarcoma cells.
    Ricci C; Landuzzi L; Rossi I; De Giovanni C; Nicoletti G; Astolfi A; Pupa S; Menard S; Scotlandi K; Nanni P; Lollini PL
    Int J Cancer; 2000 Jul; 87(1):29-36. PubMed ID: 10861449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neu differentiation factor/heregulin modulates growth and differentiation of HC11 mammary epithelial cells.
    Marte BM; Jeschke M; Graus-Porta D; Taverna D; Hofer P; Groner B; Yarden Y; Hynes NE
    Mol Endocrinol; 1995 Jan; 9(1):14-23. PubMed ID: 7760847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
    Schaefer G; Fitzpatrick VD; Sliwkowski MX
    Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.